Zacks Investment Research upgraded shares of WOLTERS KLUWER/ADR (OTCMKTS:WTKWY) from a sell rating to a hold rating in a report released on Saturday morning.
According to Zacks, “WOLTERS KLUWER is a leading global information services and publishing company. The company provides products and services globally for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer maintains operations in over 33 countries across Europe, North America, and Asia Pacific and employs approximately 19,500 people worldwide. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. “
OTCMKTS:WTKWY opened at $63.71 on Friday. WOLTERS KLUWER/ADR has a one year low of $42.87 and a one year high of $63.79. The firm has a market capitalization of $18.12 billion, a price-to-earnings ratio of 24.32, a P/E/G ratio of 2.48 and a beta of 0.97. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.74 and a current ratio of 0.76.
WOLTERS KLUWER/ADR Company Profile
Wolters Kluwer N.V., together with its subsidiaries, provides information, software, and services in Europe, North America, the Asia Pacific, and internationally. The company operates through four divisions: Health; Tax & Accounting; Governance, Risk & Compliance; and Legal & Regulatory. The Health division offers solutions in the areas of clinical decision support, clinical drug information, patient engagement, clinical terminologies, clinical surveillance, nursing education and practice, medical research, and continuing education services; and medical, nursing, and allied health journal and book publishing solutions to healthcare professionals, medical librarians, and corporate researchers.
Featured Article: How Do I Invest in Dividend Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for WOLTERS KLUWER/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WOLTERS KLUWER/ADR and related companies with MarketBeat.com's FREE daily email newsletter.